Veerhealth Care Ltd — Updates, 06-08-2025: Company Update

Date: 6th August, 2025

To,

BSE limited

Department of Corporate Services

P. J. Towers,

Dalal Street, Fort,

Mumbai-400001.

Scrip Code: 511523

Dear Sir/ Madam,

Sub: Press Release on Receipt of Order.

We are enclosing herewith the Press Release on receipt of order from one of India's leading chain

of pharmacy for manufacturing and supply of Hair Care products.

We request you to kindly take the same on record.

Thanking You.

Yours truly,

For Veerhealth Care limited

Bhavin S. Shah

Managing Director

DIN: 03129574

Reg. Off.: 629-A Gazdar House, I st Floor, Near Kalbadevi Post Office, J.S.S. Marg, Mumbai -400 002.

Tel. No.: (022) 22018582 Fax No.: (022) 22072644 E-mail: info@veerhealthcare.net Website: www.veerhealthcare.net • www.ayuveer.com

Works : Plot No. 224, Vibrant Business Park, Opp UPL, National Highway No. 8, Vapi -396191, Gujarat

..

----------------Page (0) Break----------------

Veerhealth Care Limited has received an order from one of India's leading chain of pharmacy for

manufacturing and supply of Hair Care products

Mumbai – 6th August 2025: Veerhealth Care Limited (BSE: VEERHEALTH), Ayuveer, backed by Veerhealth

Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural

ingredients. With a focus on quality and affordability, Ayuveer aims to offer an exceptional and safe daily care

experience to its customers.

Customer is one of India's leading chain of pharmacy having 5,000 + retail pharmacy outlets, having largest retail

pharmacy network in India. The Order is worth around ₹0.49 Crores to be executed in 45 days.

The Company had already received prestigious USFDA clearance after successful inspection. After this USFDA

clearance company is in a strong position to cater to Drug OTC category products across the Globe & the

Company is in talks with many Global institutional suppliers for Exports. The Company is in discussion with

a major Russian corporate group in oral care segment for exports of oral care products to Russian market.

Expected to enter Russian markets very soon.

Commenting on the achievement, Mr. Bhavin Shah - Managing Director of Veerhealth Care Limited, said, "I

am delighted to share this milestone achievement of Securing a significant order from India’s Leading Chain of

Pharmacy which not only boosts the company's current standing but also enhances its reputation and visibility in the

market. The Company is expected to get repeat orders from this client. It's a testament to the quality of our products

& services. Building a strong relationship with this client could further lead to more opportunities and larger orders

down the line.

In F.Y. 2025-26 we are expecting Total Revenues of ₹ 35-40 crores with PAT of 10%.

With oral care consumption still low per capita in India, and global demand for vegan, herbal, and specialized oral

care products growing, Veerhealth Care is well-positioned to scale. Our focus is not just on quantity, but quality with

purpose serving both urban and rural markets, while staying aligned with international ethical and health standards.”

Globally, very few small-cap companies have secured USFDA plant clearance, positioning Veerhealth Care in

a distinctive category.

In line with its “Local to Global” ambition, Veerhealth Care is actively working towards scaling its manufacturing and

export operations for products under the medical device category in the U.S. market. The Company has successfully

completed the formalities with the USFDA under this category, marking a strategic move to diversify and strengthen

its international footprint in the healthcare segment.

The company expects stronger results ahead, as it has expanded, renovated, and upgraded its manufacturing

facilities to meet USFDA standards. These steps are part of the company’s larger goal to become a leading

small-cap company globally over the next five years.

Veerhealth Care has established a new division focused on hospital care, which includes partnering with a leading

manufacturer and exporter of medical equipment. This new division will offer a range of equipment, including

ventilators, defibrillators, infusion pumps, syringe pumps, and other accessories. Company intends to supply these

products to government organizations and hospitals.

----------------Page (1) Break----------------

VeerPlast is a division of Veerhealth Care Limited. Seeing the future growth and to be cost effective the Company has

planned and expanded having started a new division VEERPLAST as a backward integration model, where in

company has blow molding and injection molding machines. Also, to compliment the export in oral care segment the

company has invested in a brush tufting (automatic and semi-automatic) and trimming line.

About The Company

VeerHealth Care Limited (BSE – 511523) is involved in the business of manufacturing and supply of Ayurvedic

medicines, oral care products & personal care products. All its finished formulations are manufactured in their own

state-of-the-art manufacturing facility at Vapi, Gujarat designed to comply with international requirements with

validated systems. The Company produces Intensive research based quality products with Expert guidance and

enormous experience of renowned Vaidya of Mumbai, Dr. Vinod C. Mehta, an Ayurvedic Practitioner for 30 years and

Dr. Rajiv Bhirud, an expert in formulations of cosmetic and personal care products. Some of its products are Health

Care, Oral Care & Personal Care products like Shampoos, Conditioners, Lipbalm, Creams, Scrubs, Bath Salts, Shower

Gels, Lotions, Ayurvedic Toothpaste & much more under Ayurvedic & Cosmetic License. Manufacturing

Certifications: Ayurvedic Mfg. License, Ayurvedic GMP, Cosmetic Mfg. License, Cosmetic GMP, ISO 9001: 2015,

Authorized Economic Operator T1 Certificate (Exporter) and Certification of Registration US FDA Labeler Code.

Veerhealth Care Limited specializes in manufacturing of Pure Vegetarian toothpaste.

The company is expecting to reach Revenue of ₹ 100 crores with PAT of 10% in next 24 to 36 months.

Disclaimer

Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking

statements are subject to certain risks and uncertainties like government actions, local, political or economic

developments, technological risks, and many other factors that could cause actual results to differ materially from

those contemplated by the relevant forward-looking statements. The Company will not be in any way responsible for

any action taken based on such statements and undertakes no obligation to publicly update these forward-looking

statements to reflect subsequent events or circumstances.

----------------Page (2) Break----------------